Literature DB >> 2303071

Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.

R Hampl1, L Foretová, J Sulcová, L Stárka.   

Abstract

Daily profiles of salivary cortisol were determined in 14 cortisol-treated children with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, and in 5 healthy sibs. The results showed considerable individual variation irrespective of the dose of hormone, reflecting the different rates of cortisol metabolism and transport. Maximum salivary cortisol levels were reached 1-2 h following oral administration of hydrocortisone. The determination of salivary cortisol may be useful for optimal dosage timing, i.e. to imitate the daily rhythm of normal cortisol secretion.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2303071     DOI： 10.1007/bf02106278

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  10 in total

1.  Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia.

Authors:  S Korth-Schutz; R Virdis; P Saenger; D M Chow; L S Levine; M I New
Journal:  J Clin Endocrinol Metab       Date:  1978-03       Impact factor: 5.958

2.  Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia.

Authors:  J Winterer; G P Chrousos; D L Loriaux; G B Cutler
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

3.  Monitoring treatment in congenital adrenal hyperplasia. Use of serial measurements of 17-OH-progesterone in plasma, capillary blood, and saliva.

Authors:  I A Hughes; J Dyas; J Robinson; R F Walker; D R Fahmy
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

Review 4.  Steroids in saliva for assessing endocrine function.

Authors:  D Riad-Fahmy; G F Read; R F Walker; K Griffiths
Journal:  Endocr Rev       Date:  1982       Impact factor: 19.871

5.  Simultaneous radioimmunoassay of androstenedione, dehydroepiandrosterone and 11-beta-hydroxyandrostenedione in plasma.

Authors:  J Fiet; B Gourmel; J M Villette; J L Brerault; R Julien; G Cathelineau; C Dreux
Journal:  Horm Res       Date:  1980

6.  A selective radioimmunoassay of androstenedione in plasma and saliva.

Authors:  Z Putz; R Hampl; A Vanŭga; J Veleminský; L Stárka
Journal:  J Clin Chem Clin Biochem       Date:  1982-10

7.  The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.

Authors:  I A Hughes; J S Winter
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

8.  17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.

Authors:  K von Schnakenburg; F Bidlingmaier; D Knorr
Journal:  Eur J Pediatr       Date:  1980-05       Impact factor: 3.183

9.  Radioimmunoassay of 11 beta-hydroxyandrostenedione in laboratory diagnostics of selected endocrine disorders.

Authors:  Z Putz; R Hampl; J Velemínský; A Kreze; J Sulcová; L Stárka
Journal:  J Clin Chem Clin Biochem       Date:  1987-10

10.  Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia.

Authors:  W Hubl; T Fehér; W Rohde; G Dörner; H Taubert; E Freymann
Journal:  Endokrinologie       Date:  1982-06
  10 in total
  2 in total

1.  The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.

Authors:  Tony Huynh; Ivan McGown; David Cowley; Ohn Nyunt; Gary M Leong; Mark Harris; Andrew M Cotterill
Journal:  Clin Biochem Rev       Date:  2009-05

2.  Salivary cortisol for monitoring circadian rhythm variation in adrenal activity during shiftwork.

Authors:  S Shinkai; S Watanabe; Y Kurokawa; J Torii
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.